United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

britannia pharmaceuticals ltd - clozapine - oral tablet - 50mg

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع خوري - khoury drug store - desvenlafaxine 50 mg - 50 mg

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - fluconazole 50mg - capsule - 50 mg - active: fluconazole 50mg excipient: ammonia solution butyl alcohol colloidal silicon dioxide ethanol gelatin   iron oxide black isopropyl alcohol lactose monohydrate magnesium stearate maize starch patent blue v potassium hydroxide propylene glycol purified water   shellac sodium laurilsulfate titanium dioxide   water - ozole is indicated for the treatment of the following conditions: 1. cryptococcosis, including cryptococcal meningitis and infections of other sites (e.g. pulmonary cutaneous). normal hosts, and patients with aids, organ transplants or other causes of immunosuppression may be treated. ozole can be used as maintenance therapy to prevent relapse of cryptococcal disease in patients with aids. 2. systemic candidiasis including candidaemia, disseninated candidasis and other forms of invasive candidal infection, including infections of the peritoneum, endocardium and pulmonary and urinary tracts. patients with malignancy, in intensive care units, receiving cytotoxic or immunosuppressive therapy, or with other factors predisposing to candidal infection may be treated. 3. mucosal candidiasis. these include oropharyngeal, oesophageal, non-invasive bronchopulmonary infections, candiduria, mucocutaneous and chronic oral atrophic candidiasis (denture sore mouth). normal hosts and patients with compromised immune function may be treated. 4. vaginal candidiasis, acute or recurrent. 5. prevention of fungal infection in immunocompromised patients considered at risk as a consequence of hiv infections or neutropenia following cytoxic chemotherapy, radiotherapy or bone marrow transplant. 6. ozole 50 mg and 150 mg capsules are also indicated for the treatment of dermatomycoses including tinea pedis, tinea corporis, tinea cruris, pityriasis versicolor & candidiasis.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

serb - primidone - oral tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

serb - primidone - oral tablet - 50mg

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - fulvestrant 50 mg/ml - 50 mg/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - alpelisib, quantity: 200 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; mannitol; sodium starch glycollate; hypromellose; magnesium stearate; purified talc; macrogol 4000; iron oxide black; iron oxide red; titanium dioxide - piqray in combination with fulvestrant, is indicated for the treatment of postmenopausal women, and men, with hormone receptor positive, her2-negative, advanced or metastatic breast cancer with a pik3ca mutation as detected by a validated test following progression on or after an endocrine-based regimen

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zentiva pharma uk ltd - trazodone hydrochloride - oral capsule - 50mg

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - clarithromycin 250mg; clarithromycin 250mg - film coated tablet - 250 mg - active: clarithromycin 250mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose iron oxide yellow macrogol 8000 magnesium stearate microcrystalline cellulose titanium dioxide active: clarithromycin 250mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose iron oxide yellow macrogol 8000 magnesium stearate microcrystalline cellulose titanium dioxide - clarithromycin is indicated for treatment of infections caused by susceptible organisms. such infections include: 1. respiratory tract infections including bronchitis, pneumonia, tonsillitis, sinusitis and pharyngitis. 2. skin and soft tissue infections such as folliculitis, cellulitis and erysipelas. 3. disseminated or localized mycobacterial infections due to mycobacterium avium or mycobacterium intracellulare. localized infections due to mycobacterium chelonae, mycobacterium fortuitum or mycobacterium kansasii. 4. prevention of disseminated mycobacterium avium complex infection in hiv-infected patients with cd4 lymphocyte counts less than or equal to 100/mm3.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - eplerenone 50mg; eplerenone 50mg - film coated tablet - 50 mg - active: eplerenone 50mg excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow purified talc purified water   sodium laurilsulfate active: eplerenone 50mg excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow purified talc purified water   sodium laurilsulfate - inspra is indicated to reduce the risk of cardiovascular death in combination with standard therapy in patients who have evidence of heart failure and left ventricular impairment within 3 to 14 days of an acute myocardial infarction.